Request Your Free Consultation

Our team is standing by to help. Call us at (800) 561-4887 or complete this form to schedule a free consultation with us.

Submitting this form does not create an attorney-client relationship.

Click for Your FREE Case Review Click for Your FREE Case Review

FDA Warns Surgical Mesh in Breast Implants Could Pose Greater Risks

By D L on April 9, 2021 - No comments

FDA Warns Surgical Mesh in Breast Implants Could Pose Greater Risks

FDA Warns Surgical Mesh in Breast Implants Could Pose Greater Risks

The U.S. Food and Drug Administration (FDA) is informing patients, caregivers and healthcare providers that certain surgical mesh products used in implant-based breast reconstruction could pose a higher risk of complications or problems for those who get them. According to the FDA alert, these acellular dermal matrix or ADM products could cause side effects and complications.

What Are the Problems?

There are a number of different methods for reconstructing the breast after a mastectomy or surgical removal of the breast. For patients who will have breast reconstruction using implants, the surgeon may use just the implant or both an implant and an ADM. The FDA has not cleared or approved ADM or mesh for use in breast reconstruction. The agency is informing healthcare providers and patients about its recent analysis and is requesting prompt reporting of adverse events so the risks can be better understood.

Patients who were implanted with FlexHD, made by MTF Biologics or AlloMax, manufactured by BD, were more likely to suffer from infections or problems that required another surgery within two years compared to patients who were treated with other mesh or no mesh, FDA officials said. Both products are made of human or animal skin.

While the FDA has approved some types of ADMs for hernia surgeries, they are not approved for post-mastectomy breast reconstruction surgeries. However, the FDA says off-label use of these products has increased over the last several years for implant-based breast reconstruction. The FDA is currently not recommending surgery or removal of the mesh. Instead, they are asking that anyone who has problems after breast reconstruction with ADM to file a report through MedWatch, which is the FDA’s Safety Information and Adverse Event Reporting System.

Defective Medical Devices

When it comes to defective products, there is no question that defective medical devices have a devastating impact on patients. When a medical device fails, the consequences are typically that the patient will need to have the device removed surgically or have to endure side effects of complications because of the device. This not only means that victims are forced to undergo additional, unnecessary surgery that could’ve been avoided, but also endure the pain, discomfort, and expenses involved in such procedures.

If you or a loved one has been affected by these or other medical devices, you may be able to seek compensation for your injuries, damages and losses by filing a product liability claim against the manufacturer. An experienced product defect lawyer who has successfully handled defective medical device cases will be able to help you better understand your legal rights and options.

Source: https://www.fda.gov/medical-devices/safety-communications/acellular-dermal-matrix-adm-products-used-implant-based-breast-reconstruction-differ-complication

Leave a Reply:


Was This Page Helpful? Yes | No

Daily Journal Top Lawyer 2020
See All Ratings And Awards

Have a question that wasn't answered here?

Call Us!

(800) 561-4887

Fill Out Our

Contact Form